BridgeBio Pharma (BBIO) Receivables - Other (2019 - 2024)
BridgeBio Pharma (BBIO) posted Receivables - Other of $200000.0 for Q3 2024, little changed sequentially from $200000.0 in Q2 2024, and down 94.12% YoY from $3.4 million in Q4 2023.
BridgeBio Pharma (BBIO) Receivables - Other (2019 - 2024) Analysis & Trends
BridgeBio Pharma has reported Receivables - Other for 6 years, with the latest figure at $200000.0 in Q3 2024.
- Quarterly Receivables - Other fell 94.12% year-over-year to $200000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $200000.0 (down 94.12% YoY) and the FY2023 annual result came in at $900000.0, down 94.64% from the prior year.
- Receivables - Other held at $200000.0 in Q3 2024 per BBIO's latest filing, from $200000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $100.4 million in Q1 2024 and troughed at $200000.0 in Q2 2024.
- A 5-year average of $14.0 million and a median of $6.4 million in 2021 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2022 and 2024: Receivables - Other soared 6956.28% in 2022, then tumbled 96.92% in 2024.
- Over 5 years, Receivables - Other stood at $8.0 million in 2020, then decreased by 21.25% to $6.3 million in 2021, then surged by 166.67% to $16.8 million in 2022, then sank by 94.64% to $900000.0 in 2023, then tumbled by 77.78% to $200000.0 in 2024.
- According to Business Quant data, Receivables - Other over the past three periods registered $200000.0, $200000.0, and $100.4 million for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BridgeBio Pharma | 15.60 Bn | 14.89 Bn | 228.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 100.40 Mn |
| Mar 31, 2024 | 100.40 Mn |
| Dec 31, 2023 | 900,000.00 |
| Dec 31, 2023 | 900,000.00 |
| Sep 30, 2023 | 3.40 Mn |
| Sep 30, 2023 | 3.40 Mn |
| Jun 30, 2023 | 6.50 Mn |
| Jun 30, 2023 | 6.50 Mn |
| Mar 31, 2023 | 10.40 Mn |
| Mar 31, 2023 | 10.40 Mn |
| Dec 31, 2022 | 16.80 Mn |
| Dec 31, 2022 | 16.80 Mn |
| Sep 30, 2022 | 32.60 Mn |
| Sep 30, 2022 | 32.60 Mn |
| Dec 31, 2021 | 6.30 Mn |
| Dec 31, 2021 | 6.30 Mn |